Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Current Assets: 2010-2024

Historic Current Assets for Iovance Biotherapeutics (IOVA) over the last 10 years, with Dec 2024 value amounting to $457.0 million.

  • Iovance Biotherapeutics' Current Assets was N/A to $429.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.1 million, marking a year-over-year change of. This contributed to the annual value of $457.0 million for FY2024, which is 48.46% up from last year.
  • Per Iovance Biotherapeutics' latest filing, its Current Assets stood at $457.0 million for FY2024, which was up 48.46% from $307.8 million recorded in FY2023.
  • Over the past 5 years, Iovance Biotherapeutics' Current Assets peaked at $457.0 million during FY2024, and registered a low of $307.8 million during FY2023.
  • In the last 2 years, Iovance Biotherapeutics' Current Assets had a median value of $382.4 million in 2023 and averaged $382.4 million.
  • Data for Iovance Biotherapeutics' Current Assets shows a peak YoY spiked of 48.46% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Current Assets (Yearly) stood at $307.8 million in 2023, then spiked by 48.46% to $457.0 million in 2024.